Long‐term follow‐up of clinical trial patients treated for chronic HCV infection with daclatasvir‐based regimens

BACKGROUND & AIMS: Daclatasvir has achieved high sustained virologic response (SVR) rates in diverse hepatitis C virus (HCV) populations. This study evaluated the long‐term efficacy and safety of daclatasvir‐based regimens administered during clinical studies. METHODS: Patients enrolled within 6...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Liver Int
Asıl Yazarlar: Reddy, K. Rajender, Pol, Stanislas, Thuluvath, Paul J., Kumada, Hiromitsu, Toyota, Joji, Chayama, Kazuaki, Levin, James, Lawitz, Eric J., Gadano, Adrian, Ghesquiere, Wayne, Gerken, Guido, Brunetto, Maurizia R., Peng, Cheng‐Yuan, Silva, Marcelo, Strasser, Simone I., Heo, Jeong, McPhee, Fiona, Liu, Zhaohui, Yang, Rong, Linaberry, Misti, Noviello, Stephanie
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2017
Konular:
Viral Hepatitis
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5947593/
https://ncbi.nlm.nih.gov/pubmed/28941023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/liv.13596
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller